PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].

By Kroll Tg, P. Sarraf, L. Pecciarini, Chang-jie Chen, E. Mueller, B. Spiegelman, J. Fletcher. Science, 2000

698 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/7c007f592f44de9cb3448457c7ef008fd7473f5e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Y. Nikiforov
2. M. Nikiforova

Citations in the corpus

• BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. (2003, background): “Another type of chromosomal rearrangement, PAX8-PPAR , has been found predominantly in follicular carcinomas (4, 5).”
• RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. (2003, methodology): “Most of the cases employed in this study were previously analyzed for PAX8-PPAR rearrangement by RT-PCR (58 patients) (23) and PPAR with 3p25 probe by fluorescence in situ hybridization (16 patients) (22, 25).”